umarjan11/Medical-qna huggingface dataset:
Question: What are the treatments for Congenital Myopathy ?

Answer: Currently, only central core disease has an effective treatment (see above). There are no known cures for any of these disorders. Supportive treatment may involve orthopedic treatments, as well as physical, occupational or speech therapy.
Question: What is the outlook for Multifocal Motor Neuropathy ?

Answer: Improvement in muscle strength usually begins within 3 to 6 weeks after treatment is started. Most patients who receive treatment early experience little, if any, disability. However, there is evidence of slow progression over many years.
Question: What is the outlook for Iniencephaly ?

Answer: The prognosis for infants with iniencephaly is extremely poor. Newborns seldom survive much past childbirth. The distortions of the babys body also pose a danger to the mother's life during delivery.
Question: What is the outlook for Kennedy's Disease ?

Answer: Kennedy's disease is slowly progressive. Individuals tend to remain ambulatory until late in the disease, although some may be wheelchair-bound during later stages. The life span of individuals with Kennedy's disease is usually normal.
Question: what research (or clinical trials) is being done for Lesch-Nyhan Syndrome ?

Answer: The gene associated with LNS is known. The NINDS supports and conducts research on genetic disorders such as LNS in an effort to find ways to prevent and treat these disorders.
Question: How many people are affected by SLC4A1-associated distal renal tubular acidosis ?

Answer: The prevalence of SLC4A1-associated distal renal tubular acidosis is unknown. The condition is most common in Southeast Asia, especially Thailand.
Question: How many people are affected by Glanzmann thrombasthenia ?

Answer: Glanzmann thrombasthenia is estimated to affect 1 in one million individuals worldwide, but may be more common in certain groups, including those of Romani ethnicity, particularly people within the French Manouche community.
Question: How many people are affected by amelogenesis imperfecta ?

Answer: The exact incidence of amelogenesis imperfecta is uncertain. Estimates vary widely, from 1 in 700 people in northern Sweden to 1 in 14,000 people in the United States.
Question: How many people are affected by glycogen storage disease type I ?

Answer: The overall incidence of GSDI is 1 in 100,000 individuals. GSDIa is more common than GSDIb, accounting for 80 percent of all GSDI cases.
Question: How many people are affected by short QT syndrome ?

Answer: Short QT syndrome appears to be rare. At least 70 cases have been identified worldwide since the condition was discovered in 2000. However, the condition may be underdiagnosed because some affected individuals never experience symptoms.
Question: How many people are affected by Klippel-Feil syndrome ?

Answer: Klippel-Feil syndrome is estimated to occur in 1 in 40,000 to 42,000 newborns worldwide. Females seem to be affected slightly more often than males.
Question: How many people are affected by leukocyte adhesion deficiency type 1 ?

Answer: Leukocyte adhesion deficiency type 1 is estimated to occur in 1 per million people worldwide. At least 300 cases of this condition have been reported in the scientific literature.
Question: Is adermatoglyphia inherited ?

Answer: Adermatoglyphia is inherited in an autosomal dominant pattern, which means one copy of the altered SMARCAD1 gene in each cell is sufficient to cause the condition. In many cases, an affected person has one parent with the condition.
Question: How many people are affected by Ohdo syndrome, Say-Barber-Biesecker-Young-Simpson variant ?

Answer: The SBBYS variant of Ohdo syndrome is estimated to occur in fewer than 1 per million people. At least 19 cases have been reported in the medical literature.
Question: How many people are affected by gastrointestinal stromal tumor ?

Answer: Approximately 5,000 new cases of GIST are diagnosed in the United States each year. However, GISTs may be more common than this estimate because small tumors may remain undiagnosed.
Question: How many people are affected by oculodentodigital dysplasia ?

Answer: The exact incidence of oculodentodigital dysplasia is unknown. It has been diagnosed in fewer than 1,000 people worldwide. More cases are likely undiagnosed.
Question: How many people are affected by mal de Meleda ?

Answer: Mal de Meleda is a rare disorder; its prevalence is unknown. The disorder was first identified on the Croatian island of Mjlet (called Meleda in Italian) and has since been found in populations worldwide.
Question: How many people are affected by alpha thalassemia X-linked intellectual disability syndrome ?

Answer: Alpha thalassemia X-linked intellectual disability syndrome appears to be a rare condition, although its exact prevalence is unknown. More than 200 affected individuals have been reported.
Question: Is multiple system atrophy inherited ?

Answer: Most cases of multiple system atrophy are sporadic, which means they occur in people with no history of the disorder in their family. Rarely, the condition has been reported to run in families; however, it does not have a clear pattern of inheritance.
Question: Is Graves disease inherited ?

Answer: The inheritance pattern of Graves disease is unclear because many genetic and environmental factors appear to be involved. However, the condition can cluster in families, and having a close relative with Graves disease or another autoimmune disorder likely increases a person's risk of developing the condition.
Question: How many people are affected by catecholaminergic polymorphic ventricular tachycardia ?

Answer: The prevalence of CPVT is estimated to be about 1 in 10,000 people. However, the true prevalence of this condition is unknown.
Question: How many people are affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis ?

Answer: RAMSVPS is a rare disorder. Only a small number of affected individuals and families, all from Saudi Arabia, have been described in the medical literature.
Question: What are the treatments for Stroke ?

Answer: With stroke, treatment depends on the stage of the disease. There are three treatment stages for stroke: prevention, therapy immediately after stroke, and rehabilitation after stroke. Stroke treatments include medications, surgery, and rehabilitation.
Question: What is (are) Psoriasis ?

Answer: Light therapy, also called phototherapy, uses ultraviolet light to treat skin lesions. Laser therapy delivers intense, focused doses of light to specific areas of the skin to clear lesions without harming surrounding tissues.
Question: Who is at risk for Breast Cancer? ?

Answer: Sometimes breast cancer occurs in women who are pregnant or have just given birth. Breast cancer occurs about once in every 3,000 pregnancies. It occurs most often between the ages of 32 and 38.
Question: What is the outlook for Atypical Chronic Myelogenous Leukemia ?

Answer: Certain factors affect prognosis (chance of recovery). The prognosis (chance of recovery) for atypical CML depends on the number of red blood cells and platelets in the blood.
Question: How to diagnose MECP2 duplication syndrome ?

Answer: How is MECP2 duplication syndrome diagnosed? A diagnosis of MECP2 duplication syndrome is often suspected based on the presence of characteristic signs and symptoms. Genetic testing can then be ordered to confirm the diagnosis.
Question: How to diagnose Hanhart syndrome ?

Answer: How is Hanhart syndrome diagnosed? A diagnosis of Hanhart syndrome is typically made based on the presence of characteristic signs and symptoms. In some cases, the diagnosis may be suspected before birth if concerning features are seen on ultrasound.
Question: What are the treatments for Anonychia congenita ?

Answer: How might anonychia congenita be treated? There is limited information regarding anonychia congenita because it is very rare.  After a careful review of the medical literature, we did not find any information about treatment for this condition.
Question: What are the treatments for Pilomatrixoma ?

Answer: How might a pilomatrixoma be treated? Pilomatrixomas are usually surgically removed (excised). In most cases, the tumors do not grow back (recur) after surgery, unless the removal was incomplete.
Question: What are the treatments for Pseudohypoaldosteronism type 2 ?

Answer: How might pseudohypoaldosteronism type 2 be treated? Pseudohypoaldosteronism may be treated with thiazide diuretics and dietary restriction of sodium.
Question: What is the outlook for Electrocardiogram ?

Answer: You don't need to take any special steps before having an electrocardiogram (EKG). However, tell your doctor or his or her staff about the medicines you're taking. Some medicines can affect EKG results.
Question: what research (or clinical trials) is being done for Hereditary Neuropathies ?

Answer: The NINDS supports research on neuromuscular disorders, such as hereditary neuropathies, aimed at learning more about these disorders and finding ways to prevent and treat them.
Question: what research (or clinical trials) is being done for Spinal Cord Infarction ?

Answer: NINDS conducts and supports research on disorders of the spinal cord such as spinal cord infarction, aimed at learning more about these disorders and finding ways to prevent and treat them.
Question: What is the outlook for Hydranencephaly ?

Answer: The outlook for children with hydranencephaly is generally poor, and many children with this disorder die before age 1. However, in rare cases, children with hydranencephaly may survive for several years or more.
Question: What is the outlook for Alexander Disease ?

Answer: The prognosis for individuals with Alexander disease is generally poor. Most children with the infantile form do not survive past the age of 6. Juvenile and adult onset forms of the disorder have a slower, more lengthy course.
Question: What is the outlook for Primary Lateral Sclerosis ?

Answer: PLS is not fatal. There is no cure and the progression of symptoms varies. Some people may retain the ability to walk without assistance, but others eventually require wheelchairs, canes, or other assistive devices.
Question: What is the outlook for Lennox-Gastaut Syndrome ?

Answer: The prognosis for individuals with Lennox-Gastaut syndrome varies. There is no cure for the disorder. Complete recovery, including freedom from seizures and normal development, is very unusual.
Question: What is the outlook for Tardive Dyskinesia ?

Answer: Symptoms of tardive dyskinesia may remain long after discontinuation of neuroleptic drugs. In many cases, the symptoms stop spontaneously, but in some cases they may persist indefinitely.
Question: What is the outlook for Complex Regional Pain Syndrome ?

Answer: The prognosis for CRPS varies from person to person. Spontaneous remission from symptoms occurs in certain individuals. Others can have unremitting pain and crippling, irreversible changes in spite of treatment.
Question: What is the outlook for Lambert-Eaton Myasthenic Syndrome ?

Answer: The prognosis for individuals with LEMS varies. Those with LEMS not associated with malignancy have a benign overall prognosis. Generally the presence of cancer determines the prognosis.
Question: How many people are affected by hereditary neuralgic amyotrophy ?

Answer: Hereditary neuralgic amyotrophy is a rare disorder, but its specific prevalence is unknown. Approximately 200 families affected by the disorder have been identified worldwide.
Question: How many people are affected by alveolar capillary dysplasia with misalignment of pulmonary veins ?

Answer: ACD/MPV is a rare disorder; its incidence is unknown. Approximately 200 infants with this disorder have been identified worldwide.
Question: How many people are affected by FG syndrome ?

Answer: The prevalence of FG syndrome is unknown, although several hundred cases have been reported worldwide. Researchers suspect that FG syndrome may be overdiagnosed because many of its signs and symptoms are also seen with other disorders.
Question: How many people are affected by congenital hemidysplasia with ichthyosiform erythroderma and limb defects ?

Answer: CHILD syndrome is a rare disorder; it has been reported in about 60 people worldwide. This condition occurs almost exclusively in females.
Question: How many people are affected by Huntington disease ?

Answer: Huntington disease affects an estimated 3 to 7 per 100,000 people of European ancestry. The disorder appears to be less common in some other populations, including people of Japanese, Chinese, and African descent.
Question: How many people are affected by hypokalemic periodic paralysis ?

Answer: Although its exact prevalence is unknown, hypokalemic periodic paralysis is estimated to affect 1 in 100,000 people. Men tend to experience symptoms of this condition more often than women.
Question: Is multiple sclerosis inherited ?

Answer: The inheritance pattern of multiple sclerosis is unknown, although the condition does appear to be passed down through generations in families. The risk of developing multiple sclerosis is higher for siblings or children of a person with the condition than for the general population.
Question: How many people are affected by vitiligo ?

Answer: Vitiligo is a common disorder, affecting between 0.5 percent and 1 percent of the population worldwide. While the condition may be more noticeable in dark-skinned people, it occurs with similar frequency in all ethnic groups.
Question: How many people are affected by systemic scleroderma ?

Answer: The prevalence of systemic scleroderma is estimated to range from 50 to 300 cases per 1 million people. For reasons that are unknown, women are four times more likely to develop the condition than men.
Question: How many people are affected by autosomal dominant nocturnal frontal lobe epilepsy ?

Answer: ADNFLE appears to be an uncommon form of epilepsy; its prevalence is unknown. This condition has been reported in more than 100 families worldwide.
Question: How many people are affected by Ghosal hematodiaphyseal dysplasia ?

Answer: Ghosal hematodiaphyseal dysplasia is a rare disorder; only a few cases have been reported in the medical literature. Most affected individuals have been from the Middle East and India.
Question: How many people are affected by Krabbe disease ?

Answer: In the United States, Krabbe disease affects about 1 in 100,000 individuals. A higher incidence (6 cases per 1,000 people) has been reported in a few isolated communities in Israel.
Question: How many people are affected by Costeff syndrome ?

Answer: Costeff syndrome affects an estimated 1 in 10,000 individuals in the Iraqi Jewish population, in which at least 40 cases have been described. Outside this population, only a few affected individuals have been identified.
Question: How many people are affected by capillary malformation-arteriovenous malformation syndrome ?

Answer: CM-AVM is thought to occur in at least 1 in 100,000 people of northern European origin. The prevalence of the condition in other populations is unknown.
Question: How many people are affected by dopamine beta-hydroxylase deficiency ?

Answer: Dopamine -hydroxylase deficiency is a very rare disorder. Fewer than 20 affected individuals, all of Western European descent, have been described in the scientific literature.
Question: What to do for Urinary Incontinence in Children ?

Answer: Eating, diet, and nutrition have not been shown to play a role in causing or preventing UI in children, though ensuring sufficient fluid intake throughout the day and avoiding caffeine intake may be helpful.
Question: What are the symptoms of Age-related Macular Degeneration ?

Answer: An early symptom of wet AMD is that straight lines appear wavy. If you notice this condition or other changes to your vision, contact your eye care professional at once. You need a comprehensive dilated eye exam.
Question: What are the treatments for Lung Cancer ?

Answer: Small cell lung cancer spreads quickly. In many cases, cancer cells have already spread to other parts of the body when the disease is diagnosed, so chemotherapy is usually the best choice. See more on treatments for small cell lung cancer.
Question: What is (are) High Blood Cholesterol ?

Answer: A desirable level for LDL (bad) cholesterol is under 100 mg/dL. Here are the ranges for LDL cholesterol levels. Do you know how your LDL level compares?
Question: What are the treatments for High Blood Cholesterol ?

Answer: The main goal of cholesterol-lowering treatment is to lower your LDL (bad) cholesterol level enough to reduce your risk of having a heart attack or diseases caused by narrowing of the arteries.
Question: What is (are) Skin Cancer ?

Answer: Melanoma is the fastest growing and most invasive type of skin cancer. This cancer arises from overgrowth of melanocytes. Melanocytes are specialized skin cells that produce a pigment called melanin.
Question: What causes Neonatal progeroid syndrome ?

Answer: What causes neonatal progeroid syndrome? The exact underlying cause of neonatal progeroid syndrome is unknown. Scientists suspect that it is a genetic condition; however, a disease-causing gene has not been identified.
Question: What are the symptoms of Hypolipoproteinemia ?

Answer: Are there other symptoms associated with hypolipoproteinemia? Some reports suggest that hypolipoproteinemia (low cholesterol levels) in general may increase the risk for development of fatty livers.
Question: How to diagnose Alopecia universalis ?

Answer: How is alopecia universalis diagnosed? A diagnosis of alopecia universalis is usually based on the signs and symptoms present in each person. In rare cases, a scalp biopsy may be needed to confirm the diagnosis.
Question: What are the treatments for Adenoameloblastoma ?

Answer: How might adenoameloblastoma be treated? Treatment may require the removal of the legion as well as the surrounding tissues. Once the treatment is complete, recurrence of the legion is very rare.
Question: what are marine toxins?

Answer: Marine toxins are naturally occurring chemicals that can contaminate certain seafood. The seafood contaminated with these chemicals frequently looks, smells, and tastes normal. When humans eat such seafood, disease can result.
Question: what research (or clinical trials) is being done for Kleine-Levin Syndrome ?

Answer: NINDS supports a broad range of clinical and basic research on diseases causing sleep disorders in an effort to clarify the mechanisms of these conditions and to develop better treatments for them.
Question: What is the outlook for Paraneoplastic Syndromes ?

Answer: There are no cures for paraneoplastic syndromes. There are no available treatments to stop progressive neurological damage. Generally, the stage of cancer at diagnosis determines the outcome.
Question: What is the outlook for Encephalopathy ?

Answer: Treating the underlying cause of the disorder may improve symptoms. However, the encephalopathy may cause permanent structural changes and irreversible damage to the brain. Some encephalopathies can be fatal.
Question: What is the outlook for Herpes Zoster Oticus ?

Answer: Generally, the prognosis of herpes zoster oticus is good. However, in some cases, hearing loss may be permanent. Vertigo may last for days or weeks. Facial paralysis may be temporary or permanent.
Question: How many people are affected by ocular albinism ?

Answer: The most common form of this disorder, ocular albinism type 1, affects at least 1 in 60,000 males. The classic signs and symptoms of this condition are much less common in females.
Question: How many people are affected by Northern epilepsy ?

Answer: Northern epilepsy appears to affect only individuals of Finnish ancestry, particularly those from the Kainuu region of northern Finland. Approximately 1 in 10,000 individuals in this region have the condition.
Question: Is familial osteochondritis dissecans inherited ?

Answer: This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.  In most cases, an affected person has one parent with the condition.
Question: Is mycosis fungoides inherited ?

Answer: The inheritance pattern of mycosis fungoides has not been determined. Although the condition has been found in multiple members of more than a dozen families, it most often occurs in people with no history of the disorder in their family and is typically not inherited.
Question: How many people are affected by succinate-CoA ligase deficiency ?

Answer: Although the exact prevalence of succinate-CoA ligase deficiency is unknown, it appears to be very rare. This condition occurs more frequently among people from the Faroe Islands in the North Atlantic Ocean.
Question: Is hereditary angiopathy with nephropathy, aneurysms, and muscle cramps syndrome inherited ?

Answer: This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.
Question: How many people are affected by preeclampsia ?

Answer: Preeclampsia is a common condition in all populations, occurring in 2 to 8 percent of pregnancies. It occurs more frequently in women of African or Hispanic descent than it does in women of European descent.
Question: How many people are affected by GRACILE syndrome ?

Answer: GRACILE syndrome is found almost exclusively in Finland, where it is estimated to affect 1 in 47,000 infants. At least 32 affected infants have been described in the medical literature.
Question: How many people are affected by purine nucleoside phosphorylase deficiency ?

Answer: Purine nucleoside phosphorylase deficiency is rare; only about 70 affected individuals have been identified. This disorder accounts for approximately 4 percent of all SCID cases.
Question: How many people are affected by Legius syndrome ?

Answer: The prevalence of Legius syndrome is unknown. Many individuals with this disorder are likely misdiagnosed because the signs and symptoms of Legius syndrome are similar to those of neurofibromatosis type 1.
Question: How many people are affected by gnathodiaphyseal dysplasia ?

Answer: The prevalence of gnathodiaphyseal dysplasia is unknown, but it is thought to be a rare disorder. A few affected individuals and families have been described in the medical literature.
Question: How many people are affected by otopalatodigital syndrome type 2 ?

Answer: Otopalatodigital syndrome type 2 is a rare disorder, affecting fewer than 1 in every 100,000 individuals. Its specific incidence is unknown.
Question: How many people are affected by otopalatodigital syndrome type 1 ?

Answer: Otopalatodigital syndrome type 1 is a rare disorder, affecting fewer than 1 in every 100,000 individuals. Its specific incidence is unknown.
Question: How many people are affected by COL4A1-related brain small-vessel disease ?

Answer: COL4A1-related brain small-vessel disease is a rare condition, although the exact prevalence is unknown. At least 50 individuals with this condition have been described in the scientific literature.
Question: How many people are affected by Fanconi anemia ?

Answer: Fanconi anemia occurs in 1 in 160,000 individuals worldwide. This condition is more common among people of Ashkenazi Jewish descent, the Roma population of Spain, and black South Africans.
Question: How many people are affected by neuroblastoma ?

Answer: Neuroblastoma is the most common cancer in infants younger than 1 year. It occurs in 1 in 100,000 children and is diagnosed in about 650 children each year in the United States.
Question: How many people are affected by leptin receptor deficiency ?

Answer: The prevalence of leptin receptor deficiency is unknown. It has been estimated to account for up to 3 percent of individuals with severe obesity and hyperphagia that begins in early childhood.
Question: How many people are affected by Gillespie syndrome ?

Answer: The prevalence of Gillespie syndrome is unknown. Only a few dozen affected individuals have been described in the medical literature. It has been estimated that Gillespie syndrome accounts for about 2 percent of cases of aniridia.